Mortality at 30 days
It is very uncertain whether summary of findings TIVA changes mortality At 30 days compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Intraoperative hypotension (defined by study authors as change in MAP from baseline)
1 finding from 1 review
Length of stay in PACU
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Intervention not reported
Mortality during hospital stay · neonates requiring intubation and ventilation
The intervention showed no clear difference in mortality during hospital stay (moderate certainty).
1 finding from 1 review
Intervention not reported
Length of NICU stay (days) · neonates requiring intubation and ventilation
1 finding from 1 review
Intervention not reported
PIPP score during drug infusion Range of scale 0‐21 for infants < 28 weeks' PMA and 0‐18 for infants > 36 weeks' PMA. Lower score = less pain (Stevens 1996) · neonates requiring intubation and ventilation
The intervention showed no clear difference in PIPP score during drug infusion Range of scale 0‐21 for infants < 28… (moderate certainty).
1 finding from 1 review
Intervention not reported
Poor neurological outcome by 28 days' postnatal age · neonates requiring intubation and ventilation
The intervention showed no clear difference in poor neurological outcome by 28 days' postnatal age (moderate certainty).
1 finding from 1 review
Intervention not reported
PIPP score during drug infusion Range of scale 0‐21 for infants < 28 weeks' PMA and 0‐18 for infants > 36 weeks' PMA. Lower score = less pain (Stevens 1996) · neonates requiring intubation and ventilation
The intervention showed no clear difference in PIPP score during drug infusion Range of scale 0‐21 for infants < 28… (moderate certainty).
1 finding from 1 review
Intervention not reported
Poor neurological outcome by 28 days' postnatal age · neonates requiring intubation and ventilation
The intervention probably leads to higher poor neurological outcome by 28 days' postnatal age (moderate certainty).
1 finding from 1 review
Odds of reversion · patients with supraventricular tachycardia
1 finding from 1 review
no estimate extracted
622 participants
Moderate
Major adverse event: hypotension · patients with supraventricular tachycardia
1 finding from 1 review
no estimate extracted
306 participants
Low
Length of hospital stay · patients with supraventricular tachycardia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction · patients with supraventricular tachycardia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Para/propacetamol vs placebo see footnote1 · patients with postoperative pain
The intervention leads to higher para/propacetamol vs placebo see footnote1 (high certainty).
1 finding from 1 review
Intervention not reported
Propacetamol vs placebo see footnote1 · patients with postoperative pain
The intervention may leads to higher propacetamol vs placebo see footnote1 (low certainty).
1 finding from 1 review
Intervention not reported
Para/propacetamol vs NSAIDs see footnote1 · patients with postoperative pain
It is very uncertain whether the intervention changes para/propacetamol vs NSAIDs see footnote1 (very low certainty).
1 finding from 1 review
Intervention not reported
Paracetamol vs NSAIDs see footnote1 · patients with postoperative pain
It is very uncertain whether the intervention changes paracetamol vs NSAIDs see footnote1 (very low certainty).
1 finding from 1 review
Intervention not reported
Propacetamol vs NSAIDs see footnote1 · patients with postoperative pain
It is very uncertain whether the intervention changes propacetamol vs NSAIDs see footnote1 (very low certainty).
1 finding from 1 review
Intervention not reported
Paracetamol vs propacetamol see footnote1 · patients with postoperative pain
The intervention showed no clear difference in paracetamol vs propacetamol see footnote1 (low certainty).
1 finding from 1 review